Dr. Wei Wu is a Professor in the Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China. His research interest is in the field of oral drug delivery systems and in vivo fate of drug nanocarriers. He and coworkers invented novel water-quenching ACQ fluorescent dyes to probe the in vivo fate of versatile nanoparticles administered via different routes. Dr. Wu graduated from School of Pharmacy, the Second Military Medical University with a bachelor degree in 1992 and a master degree in 1996. He received a Ph.D. in 1999 from School of Pharmacy, West China University of Medical Sciences. In 2000, he joined School of Pharmacy, Fudan University. He ever served his school as a vice dean. He is an associate editor for Chin Chem Lett and J Biomed Nanotech, and is also listed in the Editorial Board of more than ten professional journals including AAPS PharmSciTech, Acta Pharm Sin, Arch Pharm Res, Asian J Pharm Sci, Curr Drug Deliv, Drug Deliv Lett, Heliyon, J Drug Deliv Sci Tech, Int J Pharm, J Chin Pharm Sci, Pharm Res, and Processes. Dr. Wu works as guest editors for Acta Pharm Sin B, Adv Drug Deliv Rev, Int J Pharm and Pharmaceutics. He has published more than 200 peer-reviewed articles in the field of pharmaceutics and nanomedicine.
Dr. Wei He is an Associate Professor at the College of Pharmaceutical Science, China Pharmaceutical University (since Jul, 2012). He obtained his Ph.D. degree from Fudan University, worked as a project leader in CSPC Pharmaceutical Co., Ltd. from 2007 to 2009, as a researcher at Alberta University (Canada) and as a visiting scholar at Harvard University from Nov, 2018 to Oct, 2019. His current research interest mainly includes drug delivery pharmaceutical science. He is listed in the editor board of several academic journals, such as Chin Chem Lett, Acta Pharm Sin, Front Nanotechnol and Front Drug Deliv. He works as a guest editor for Acta Pharm Sin B. He has published over 70 peer-reviewed papers in drug delivery and pharmaceutical science.
Footnotes
Peer review under responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.